首页/数据集/Demographics, clinical and molecular characteristics of subjects with GD.

Demographics, clinical and molecular characteristics of subjects with GD.

NIAID Data Ecosystem2026-03-13 收录

数据链接：

https://figshare.com/articles/dataset/Demographics_clinical_and_molecular_characteristics_of_subjects_with_GD_/16868373 数据链接链接失效反馈

官方服务：

资源简介：

Demographics, clinical and molecular characteristics of subjects with GD.

应用场景：

创建时间：

2021-10-25

放射性碘治疗

Graves病

Background: Graves’s disease (GD) is the most common cause of hyperthyroidism. Maximal 30% of pediatric GD patients achieve remission with antithyroid drugs. The majority of patients the

DataCite Commons2025-05-01 更新100

Table_1_Identification of Novel Environmental Substances Relevant to Pediatric Graves’ Disease.xlsx

Graves病

环境病毒学

Graves’ disease (GD) is the most common cause of hyperthyroidism, yet a relatively rare disease in the pediatric population. GD is a complex disorder influenced by both genetic and environmental facto

NIAID Data Ecosystem50

Multi-omics profiling uncovers candidate genes for the treatment of graves’ disease

Graves病

药物靶点预测

This Summary-data-based Mendelian randomization (SMR) study investigates the genetic basis of Graves’ disease (GD) using a multi-omics approach to elucidate biological mechanisms and identify therapeu

DataCite Commons2026-02-18 更新30

Additional file 2

Graves病

孟德尔随机化

This study aims to establish a foundation for the precise prevention and treatment of GD by identifying potential therapeutic targets among plasma proteins. Initially, to systematically screen for pro

NIAID Data Ecosystem70

ISCALIMAB-KAHALY-SUPPLEMENTAL

Graves病

单克隆抗体

Context The CD40-CD154 co-stimulatory pathway plays an important role in the pathogenesis of Graves’ disease (GD) by promoting auto-reactive B cell activation. Objective Evaluate efficac

DataCite Commons2025-06-01 更新50

Demographics, clinical and molecular characteristics of subjects with GD.

资源简介：

相关数据集